Heron Therapeutics (HRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 1,261 | 369 | 412 | 0 | 5,391 |
| Gross Profit | 1,261 | 369 | 412 | N/A | 5,391 |
| Operating Expenses | 11,503 | 23,814 | 24,045 | 18,864 | 13,864 |
| Operating Income | -10,242 | -23,445 | -23,633 | -18,864 | -8,473 |
| Other Income | 24 | 520 | 3,511 | 24,249 | 263 |
| Pre-tax Income | -10,218 | -22,925 | -20,122 | 5,385 | -8,210 |
| Income Tax | -122 | N/A | 41 | 119 | N/A |
| Net Income Continuous | -10,096 | -22,925 | -20,163 | 5,266 | -8,210 |
| Net Income Discontinuous | 68 | -200 | N/A | N/A | N/A |
| Net Income | $-10,028 | $-23,125 | $-20,163 | $5,266 | $-8,210 |
| EPS Basic Total Ops | -6.20 | -15.00 | -20.80 | 16.60 | -26.20 |
| EPS Basic Continuous Ops | -6.20 | -14.80 | -20.40 | 17.40 | -26.00 |
| EPS Basic Discontinuous Ops | 0.04 | -0.13 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -6.20 | -15.00 | -20.80 | 16.60 | -26.20 |
| EPS Diluted Continuous Ops | -6.20 | -14.80 | -20.40 | 17.40 | -26.00 |
| EPS Diluted Discontinuous Ops | 0.04 | -0.13 | N/A | N/A | N/A |
| EBITDA(a) | $-9,886 | $-23,033 | $-23,344 | $-19,108 | $-8,027 |